We look forward to sharing additional Phase 1/2 data next week at the Muscular Dystrophy Association's annual meeting and ...

Thank you, Julissa. 2025 was a truly transformative year for Verastem as we transition to a commercial stage company ...

BBOT debuted as a publicly traded oncology company developing a differentiated portfolio of three clinical-stage small molecule inhibitors targeting the RAS pathway.Announced encouraging preliminary ...

Bowman Consulting Group Ltd. ( BWMN) Q4 2025 Earnings Call March 5, 2026 9:00 AM EST ...

Each occupant of a turbine-powered aircraft is assumed to weigh 200 lb., thus allowing for stowed luggage and carry-on items. In the case of piston-engine airplanes, we assume each occupant weighs 170 ...

Good afternoon and welcome to Samsara's Fourth Quarter Fiscal 2026 Earnings Call. I'm Mike Chang, Samsara's Senior Vice President of Finance. Joining me today are Samsara's Chief Executive Officer and ...

COPENHAGEN, Denmark, March 5, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its ...

Late-stage gene therapy pipeline for rare and retinal diseases advancing toward key catalysts RGX-202 for Duchenne muscular dystrophy: New Phase I/II data ...

Late-stage gene therapy pipeline for rare and retinal diseases advancing toward key catalysts RGX-202 for Duchenne muscular dystrophy: New Phase I/II data at ...

Fourth Quarter and Full Year 2025 Highlights Fourth quarter high-speed broadband homes passed expanded by 27%Fourth quarter total high-speed broadband subscribers grew by 3%Fourth quarter total intern ...